US 11406716
Modified RNAi agents
granted A61KA61K48/00A61P
Quick answer
US patent 11406716 (Modified RNAi agents) held by Alnylam Pharmaceuticals, Inc. expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K48/00, A61P, A61P31/12, A61P31/18